NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OPKO Health

OPKO Health

Miami, Floridaopko.com

Overview

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets. It operates through two segments: Diagnostics, which includes the clinical laboratory operations of BioReference, and Pharmaceuticals, which has operations in several countries and focuses on research and development. The company's products include treatments for kidney disease and growth hormone deficiency, as well as diagnostic tests like the 4Kscore for prostate cancer. While its primary function is not investment, it makes strategic acquisitions and investments in other companies.

Portfolio Companies

2

Website

opko.com

Investments

OPKO Health investments
CompanyDateStageLead
HealthSnapNov 2021VC RoundLead
ElkosRx, LLCAug 2017Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMiami, Florida
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.